Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : OPGN save search
OpGen Announces Acquisition of Preferred Stock by David Lazar
Published: 2024-03-25 (Crawled : 20:00) - globenewswire.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: 105.16%
H: 1.59%
C: -23.04%
acquisition
OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-14 (Crawled : 21:00) - globenewswire.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: -3.0%
H: 5.18%
C: 0.99%
business update financial results
OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds
Published: 2023-10-12 (Crawled : 17:00) - globenewswire.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: 391.07%
H: 132.73%
C: -44.24%
OpGen Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-10 (Crawled : 20:00) - globenewswire.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: -11.16%
H: 1.67%
C: -14.63%
business update financial results
OpGen’s Subsidiary Ares Genetics Releases New Features to its AREScloud Offering
Published: 2023-08-07 (Crawled : 12:00) - globenewswire.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: 2.28%
H: 1.63%
C: -6.67%
offering
OpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration Agreement
Published: 2023-08-03 (Crawled : 12:00) - globenewswire.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: 3.42%
H: 1.64%
C: -4.43%
collaboration agreement
OpGen to Provide Business Update and Financial Results for the Second Quarter 2023 on August 10th at 4:30 p.m. Eastern Time
Published: 2023-08-03 (Crawled : 12:00) - globenewswire.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: 3.42%
H: 1.64%
C: -4.43%
business update financial results
OpGen’s Subsidiary Curetis Meets Milestones of Extended and Expanded R&D Collaboration with FIND
Published: 2023-07-19 (Crawled : 12:00) - globenewswire.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: 0.14%
H: 7.53%
C: -1.67%
collaboration
OpGen Subsidiary Ares Genetics Successfully Maintains Key Patent under Opposition in Europe
Published: 2023-06-26 (Crawled : 12:00) - globenewswire.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: 0.0%
H: 0.83%
C: 0.35%
europe patent
OpGen’s Subsidiary Curetis Receives Batch of Ten New C-Series Unyvero A30 Instruments
Published: 2023-06-22 (Crawled : 12:00) - globenewswire.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: -1.59%
H: 4.84%
C: 0.0%
OpGen Presents Unyvero Urinary Tract Infection Panel Trial Results at ASM Microbe 2023 Conference
Published: 2023-06-20 (Crawled : 12:00) - globenewswire.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: 0.0%
H: 0.0%
C: -5.0%
conference infection trial results
Point of Care Molecular Diagnostics Market worth $3.4 billion | MarketsandMarkets
Published: 2023-06-14 (Crawled : 10:00) - prnewswire.com
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -0.91%
H: 0.9%
C: 0.31%
DHR | $235.51 -0.36% 0.0% 2.3M
|
Health Technology
|
| O: 0.69%
H: 0.37%
C: -1.85%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 1.42%
H: 0.81%
C: -0.06%
QDEL | News M | $39.09 2.17% 2.12% 1.1M
|
Health Technology
|
| O: -0.03%
H: 0.83%
C: -1.34%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -0.91%
H: 0.9%
C: 0.31%
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: 4.41%
H: 0.0%
C: -10.02%
CODX | $1.16 4.2% 18K
|
Health Technology
|
| O: -1.89%
H: 1.92%
C: 0.0%
care diagnostics molecular market
OpGen Reports First Quarter 2023 Financial Results and Provides Business Update
Published: 2023-05-15 (Crawled : 20:00) - ir.opgen.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: 1.5%
H: 4.28%
C: -1.46%
business update financial results
OpGen to Provide Business Update and Financial Results for the First Quarter 2023 on May 15th at 4:30 p.m. Eastern Time
Published: 2023-05-08 (Crawled : 12:00) - globenewswire.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: 3.47%
H: 4.67%
C: -6.32%
business update financial results
OpGen Announces Closing of $3.5 Million Public Offering
Published: 2023-05-04 (Crawled : 20:00) - globenewswire.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: 2.04%
H: 7.73%
C: 1.8%
offering
OpGen Announces Pricing of $3.5 Million Public Offering
Published: 2023-05-02 (Crawled : 01:00) - globenewswire.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: -8.34%
H: 2.31%
C: -4.41%
offering
OpGen’s Subsidiary Curetis Meets All Remaining Key Milestones in R&D Collaboration with FIND
Published: 2023-04-26 (Crawled : 21:00) - ir.opgen.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: 10.76%
H: 3.0%
C: -1.94%
collaboration
OpGen Enters Into Distribution Agreement for Unyvero in the U.S. with Fisher Healthcare
Published: 2023-04-18 (Crawled : 21:00) - globenewswire.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: 0.95%
H: 5.66%
C: 3.77%
distribution agreement
OpGen Submits De Novo request to the U.S. FDA for Unyvero Urinary Tract Infection Panel
Published: 2023-04-18 (Crawled : 12:00) - globenewswire.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: 3.55%
H: 1.6%
C: -16.0%
fda infection
OpGen’s Subsidiary Curetis Signs Expansion of R&D Collaboration with FIND
Published: 2023-04-05 (Crawled : 12:00) - globenewswire.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: -0.76%
H: 3.82%
C: 1.53%
expansion collaboration
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.